Smart control of CAR-T cells: emerging strategies for safer and more effective cancer immunotherapy

TL;DR

This paper reviews new strategies to make CAR-T cell therapy safer and more effective by using smart control systems.

Contribution

The paper summarizes recent advances in programmable and context-dependent control mechanisms for CAR-T cells.

Findings

Smart control systems can regulate CAR-T activity dynamically for improved safety and precision.

Inducible CAR expression and logic-gated receptors are promising approaches for controlled activation.

Synthetic biology tools like sensor circuits enable real-time adjustments in CAR-T function.

Abstract

Chimeric Antigen Receptor (CAR)-T cell therapy has developed cancer immunotherapy but remains restricted by severe toxicities, antigen escape, and loss of efficacy in solid tumors. Recent advances in smart control systems aim to enhance the safety and precision of CAR-T therapies through tunable, reversible, and context-dependent mechanisms. These include the importance of inducible CAR expression, logic-gated receptors, and external control systems using drugs, light, or biomaterials. Synthetic biology approaches integrating sensor circuits and feedback loops are paving the way for programmable immunity, enabling dynamic adjustment of CAR-T activity in real time. The aim of this study is to review recent advances in strategies that enable smart controlled and designed activity of CAR-T cells for safer and more effective cancer immunotherapy. It seeks to summarize key molecular, genetic, and synthetic approaches designed to regulate CAR-T cell activation, persistence, and cytotoxicity with high precision.

Figures